AUGUSTA — Maine Gov. Janet Mills called the moratorium on the use of the Johnson & Johnson COVID-19 vaccine a blip in the distribution of the vaccines.
On Tuesday morning, the state and federal governments temporarily shelved the Johnson & Johnson vaccines because six women developed blood clots in their brains after receiving it.
Maine Center for Disease Control and Prevention Director Dr. Nirav Shah said a federal advisory commission was scheduled to review the data surrounding the Johnson & Johnson vaccine Wednesday.
The governor said the mobile vaccination unit was going to stop using the Johnson & Johnson vaccine until the Food and Drug Administration decided whether to OK its continued use.
“We do hope to get an increase in the Moderna and Pfizer vaccines to keep us on track. And we will stay on track,” she said.
Shah said anyone who received the vaccine under review who experiences severe headaches, abdominal pain, leg pain or severe shortness of breath should immediately contact their doctor.
He said any vaccination sites with the Johnson & Johnson vaccines would have that vaccine replaced by either the Pfizer or the Moderna vaccine.
Mills said more than a third of the state’s eligible population has been vaccinated.
She said less than 6 percent of the people already vaccinated have received the Johnson & Johnson vaccine.